SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

Clinical trial NCT06927180 · RECRUITING

Trial details

NCT number: NCT06927180
Sponsor: Henan Cancer Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Start date: 2025-04-16
Primary completion: 2029-05-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.